Rundo Selects OmniComm’s TrialMaster® and TrialOne® eClinical Solutions

Leading Shanghai-headquartered CRO signs multi-year contracts FORT LAUDERDALE, Fla., April 11, 2019 (GLOBE NEWSWIRE) — Rundo International Pharmaceutical Research & Development Co., Ltd. (Rundo), a prominent, Shanghai-headquartered contract research organization (CRO) has selected eClinical solutions from OmniComm Systems, Inc. (OTCQX:… Read More